FTO inhibitors may represent a potential function to alleviate the pathological changes of chronic inflammation imprints and immune disorders in CoSCs, maintaining their pluripotency and differentiation balance under inflammatory bowel disease. The gene discussed is FTO; the disease is immune system disorder.